| 1 |
34045606 | Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia. | 2021 May 27 |
2 |
| 2 |
32341465 | Diabetes downregulates peptide transporter 1 in the rat jejunum: possible involvement of cholate-induced FXR activation. | 2020 Nov |
1 |
| 3 |
30920307 | FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection. | 2019 Aug 1 |
4 |
| 4 |
29235094 | Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo. | 2018 Mar |
1 |
| 5 |
30139242 | Farnesoid X Receptor Activation Modulates Calcium Homeostasis in Rat Aortic Vascular Smooth Muscle Cells. | 2018 Aug 31 |
1 |
| 6 |
26710942 | Farnesoid X receptor regulates vasoreactivity via Angiotensin II type 2 receptor and the kallikrein-kinin system in vascular endothelial cells. | 2016 Mar |
1 |
| 7 |
21924881 | FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. | 2013 Feb |
3 |
| 8 |
23124354 | Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy. | 2013 May 15 |
1 |
| 9 |
20026603 | Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells. | 2010 Feb 19 |
1 |
| 10 |
17065154 | Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation. | 2006 Dec 29 |
3 |
| 11 |
15644430 | Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis. | 2005 May |
1 |
| 12 |
12754200 | Farnesoid X receptor regulates bile acid-amino acid conjugation. | 2003 Jul 25 |
1 |
| 13 |
14623915 | Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. | 2003 Dec |
1 |
| 14 |
11706036 | Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. | 2002 Jan 25 |
1 |